We bring you our round-up of the latest legal and commercial issues for life sciences businesses.
As we approach the end of the transition period, we cover the key points businesses in the life sciences sector should know about the immigration changes ahead.
We also look at the latest updates from the MHRA on electronic health records, and recent developments relating to the European Health Data Space.
Finally, the latest entries to our Life Sciences A to Z give an overview of the incentives offered to sponsors of orphan medicines and, separately, the risks and benefits of outsourcing arrangements commonly used by businesses in the sector.
A link to the web version of this email update is available here. If you would like to receive these updates via email, please subscribe.
Charlotte Tillett
Gustaf Duhs